TATA Health International Holdings Ltd.

As of December 31, 2025, TATA Health International Holdings Ltd. carries a market capitalization of 315.70M, placing it among publicly traded companies globally. Its enterprise value stands at 323.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, TATA Health International Holdings Ltd. has 242.85M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, TATA Health International Holdings Ltd. maintains a current ratio of 0.50, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 20, 2026, TATA Health International Holdings Ltd.'s stock has gained approximately 508.33% over the past 52 weeks. The 50-day moving average sits at 2.38, while the 200-day moving average is 1.77.

As of December 31, 2025, TATA Health International Holdings Ltd. holds 17.92M in cash and equivalents against 25.87M in total debt, resulting in a net debt position of -7.66M. Total book value stands at -54.44M, with working capital of -70.91M providing operational flexibility.